Taipei Exchange - Delayed Quote TWD
United Orthopedic Corporation (4129.TWO)
99.80
+0.10
+(0.10%)
At close: 1:30:37 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
4,653,130
4,653,130
3,929,887
3,168,680
2,570,866
Cost of Revenue
1,030,809
1,030,809
893,517
805,697
729,522
Gross Profit
3,622,321
3,622,321
3,036,370
2,362,983
1,841,344
Operating Expense
2,998,310
2,998,310
2,499,670
2,014,223
1,681,428
Operating Income
624,011
624,011
536,700
348,760
159,916
Net Non Operating Interest Income Expense
-32,373
-32,373
-37,041
-19,714
-15,631
Pretax Income
575,104
575,104
509,226
303,021
74,594
Tax Provision
114,723
114,723
120,917
79,440
21,717
Net Income Common Stockholders
456,428
456,428
384,201
221,533
52,271
Diluted NI Available to Com Stockholders
456,428
456,428
384,201
221,533
52,271
Basic EPS
4.74
--
4.50
2.84
0.37
Diluted EPS
4.74
--
4.18
2.51
0.37
Basic Average Shares
96,292.83
--
85,378
78,112
77,854
Diluted Average Shares
96,292.83
--
91,914.12
88,092
78,114
Total Expenses
4,029,119
4,029,119
3,393,187
2,819,920
2,410,950
Net Income from Continuing & Discontinued Operation
456,428
456,428
384,201
221,533
52,271
Normalized Income
468,454.18
468,454.18
379,191.83
221,467.33
51,201.32
Interest Income
10,817
10,817
7,101
4,392
2,010
Interest Expense
43,190
43,190
44,142
24,106
17,641
Net Interest Income
-32,373
-32,373
-37,041
-19,714
-15,631
EBIT
618,294
618,294
553,368
327,127
92,235
EBITDA
1,078,214
1,078,214
949,839
662,384
401,968
Reconciled Cost of Revenue
1,030,809
1,030,809
893,517
805,697
729,522
Reconciled Depreciation
459,920
459,920
396,471
335,257
309,733
Net Income from Continuing Operation Net Minority Interest
456,428
456,428
384,201
221,533
52,271
Total Unusual Items Excluding Goodwill
-15,023
-15,023
6,569
89
1,509
Total Unusual Items
-15,023
-15,023
6,569
89
1,509
Normalized EBITDA
1,093,237
1,093,237
943,270
662,295
400,459
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-2,996.82
-2,996.82
1,559.83
23.33
439.32
12/31/2021 - 12/31/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6649.TWO Taiwan Biomaterial Co., Ltd.
37.40
-1.45%
3218.TWO Universal Vision Biotechnology Co., Ltd.
201.50
+9.81%
4736.TW TaiDoc Technology Corporation
126.50
-1.56%
6861.TW InnoCare Optoelectronics Corporation
56.60
+3.28%
4138.TWO Dynamic Medical Technologies Inc.
82.50
0.00%
1781.TWO Health & Life Co., Ltd.
13.90
0.00%
1788.TWO Hi-Clearance Inc.
142.50
-0.70%
6767.TWO Wiltrom Co., Ltd.
32.30
0.00%
4121.TWO Rossmax International Ltd.
15.10
0.00%
4188.TWO AmCad BioMed Corporation
14.20
+1.43%